U.S.-China Decoupling Poses Supply-Chain Risks for Drug Companies

U.S.-China Decoupling Poses Supply-Chain Risks for Drug Companies·The Wall Street Journal
In this article:

A proposed bill in Congress targets Chinese biotech businesses that play an important role in developing drugs.

Advertisement